All Stories

  1. Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data
  2. Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes
  3. Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes
  4. Vitamin D insufficiency in infants with increased risk of developing type 1 diabetes: a secondary analysis of the POInT Study
  5. Factors assessed in the first year of a longitudinal study predict subsequent study visit compliance: the TEDDY study
  6. SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood
  7. Islet autoantibody screening in at-risk adolescents to predict type 1 diabetes until young adulthood: a prospective cohort study
  8. Refining the Definition of Stage 1 Type 1 Diabetes: An Ontology-Driven Analysis of the Heterogeneity of Multiple Islet Autoimmunity
  9. Home Capillary Sampling and Screening for Type 1 Diabetes, Celiac Disease, and Autoimmune Thyroid Disease in a Swedish General Pediatric Population: The Triad Study
  10. Pancreatic Islet Β-Cell Function in Individuals with Multiple Islet Autoantibodies and Effects of Gluten-Free Diet
  11. The emotional well‐being of parents with children at genetic risk for type 1 diabetes before and during participation in the POInT ‐study
  12. Elevations in blood glucose before and after the appearance of islet autoantibodies in children
  13. Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children
  14. HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children
  15. Possible Relationship between the HLA-DRA1 Intron Haplotype of Three Single-Nucleotide Polymorphisms in Intron 1 of the HLA-DRA1 Gene and Autoantibodies in Children at Increased Genetic Risk for Autoimmune Type 1 Diabetes
  16. Two-age islet-autoantibody screening for childhood type 1 diabetes: a prospective cohort study
  17. Multiplex agglutination-PCR (ADAP) autoantibody assays compared to radiobinding autoantibodies in type 1 diabetes and celiac disease
  18. Long-Term GAD-alum Treatment Effect on Different T-Cell Subpopulations in Healthy Children Positive for Multiple Beta Cell Autoantibodies
  19. Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories
  20. Childhood Height Growth Rate Association With the Risk of Islet Autoimmunity and Development of Type 1 Diabetes
  21. Heterogeneity of DKA Incidence and Age-Specific Clinical Characteristics in Children Diagnosed With Type 1 Diabetes in the TEDDY Study
  22. Is staff consistency important to parents’ satisfaction in a longitudinal study of children at risk for type 1 diabetes: the TEDDY study
  23. Heterogeneity of beta-cell function in subjects with multiple islet autoantibodies in the TEDDY family prevention study - TEFA
  24. Islet Autoantibody Type-Specific Titer Thresholds Improve Stratification of Risk of Progression to Type 1 Diabetes in Children
  25. Supplementation with Bifidobacterium longum subspecies infantis EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocol
  26. Is Staff Consistency Important to Parents’ Satisfaction in a Longitudinal Study of Children at Risk for Type 1 Diabetes: The TEDDY Study
  27. Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet Cohorts
  28. Islet autoimmunity and risk of type 1 diabetes from joint analyses of birth-cohort studies
  29. 589-P: Effect of Oral Insulin (OI) on Combined Glucose and C-Peptide Endpoints in Individuals at High-Risk for Type 1 Diabetes (T1D)
  30. Advances in Type 1 Diabetes Prediction Using Islet Autoantibodies: Beyond a Simple Count
  31. Children’s erythrocyte fatty acids are associated with the risk of islet autoimmunity
  32. First-appearing islet autoantibodies for type 1 diabetes in young children: maternal life events during pregnancy and the child’s genetic risk
  33. Beta cell function in participants with single or multiple islet autoantibodies at baseline in the TEDDY Family Prevention Study: TEFA
  34. Factors Associated With the Decline of C-Peptide in a Cohort of Young Children Diagnosed With Type 1 Diabetes
  35. Characterization of plasma lipidomics in adolescent subjects with increased risk for type 1 diabetes in the DiPiS cohort
  36. A combined risk score enhances prediction of type 1 diabetes among susceptible children
  37. 248-OR: Visualizing Heterogeneous Islet Autoantibody Trajectories of Children Who Develop T1D from Multisite Birth Cohort Studies
  38. 342-OR: Optimal Ages for Screening for T1D Risk in Children
  39. 348-OR: Metabolic Phenotype of Autoantibody Positive (AbPos) Long-Term Nonprogressors (LTNPs) to Type 1 Diabetes (T1D)
  40. Parental anxiety after 5 years of participation in a longitudinal study of children at high risk of type 1 diabetes
  41. First European Case of Simultaneous Liver and Pancreas Transplantation as Treatment of Wolcott-Rallison Syndrome in a Small Child
  42. Longitudinal Metabolome-Wide Signals Prior to the Appearance of a First Islet Autoantibody in Children Participating in the TEDDY Study
  43. DPVis: Visual Analytics with Hidden Markov Models for Disease Progression Pathways
  44. Decreased HLA-DQ expression on peripheral blood cells in children with varying number of beta cell autoantibodies
  45. Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
  46. Metabolite-related dietary patterns and the development of islet autoimmunity
  47. The relationship between breastfeeding and reported respiratory and gastrointestinal infection rates in young children
  48. Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
  49. 211-OR: Analysis of Longitudinal Autoantibody Profiles and the Progression Rates to Type 1 Diabetes
  50. 1671-P: Comorbid Autoimmune Disease in Participants at Risk for Type 1 Diabetes
  51. 1690-P: Predicting Onset of Type 1 Diabetes Using a Novel Interaction Model
  52. 1345-P: Presymptomatic and Clinical T1D in The U.S., Sweden, and Finland: Joint Analysis of Four Birth Cohort Studies
  53. 163-OR: Sensitivity Analysis of Alternate Definitions of Multiple Islet Autoantibody Positivity
  54. Practical management in Wolcott‐Rallison syndrome with associated hypothyroidism, neutropenia, and recurrent liver failure: A case report
  55. The Environmental Determinants of Diabetes in the Young (TEDDY) Study: 2018 Update
  56. Effect of screening for type 1 diabetes on early metabolic control: the DiPiS study
  57. Childhood thyroid autoimmunity and relation to islet autoantibodies in children at risk for type 1 diabetes in the diabetes prediction in skåne (DiPiS) study
  58. First trimester enterovirus IgM and beta cell autoantibodies in mothers to children affected by type 1 diabetes autoimmunity before 7 years of age
  59. Influence of early-life parental severe life events on the risk of type 1 diabetes in children: the DiPiS study
  60. Cesarean Section on the Risk of Celiac Disease in the Offspring: The Teddy Study
  61. Association Between Early-Life Antibiotic Use and the Risk of Islet or Celiac Disease Autoimmunity
  62. Safety and efficacy of autoantigen-specific therapy with 2 doses of alum-formulated glutamate decarboxylase in children with multiple islet autoantibodies and risk for type 1 diabetes: A randomized clinical trial
  63. Joint modeling of longitudinal autoantibody patterns and progression to type 1 diabetes: results from the TEDDY study
  64. Analgesic antipyretic use among young children in the TEDDY study: no association with islet autoimmunity
  65. Psychological Manifestations of Celiac Disease Autoimmunity in Young Children
  66. Are Perinatal Events Risk Factors for Childhood Thyroid Autoimmunity?
  67. Cord blood insulinoma-associated protein 2 autoantibodies are associated with increased risk of type 1 diabetes in the population-based Diabetes Prediction in Skåne study
  68. Reduced morbidity at diagnosis and improved glycemic control in children previously enrolled in DiPiS follow-up